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Abstract: Background: Despite its importance, determination of
competence to consent to organ donation varies widely based on local
standards. We piloted a new tool to aid transplant centers in donor
assessment.
Methods: We assessed competence-related abilities among potential
living liver donors (LDs) in the nine-center A2ALL study. Prospective
LDs viewed an educational video and were queried to assess
Understanding, Appreciation, Reasoning, and ability to express a Final
Choice using theMacArthur Competence Assessment Tool for Clinical
Research, adapted for computerized administration in LDs
(“MacLiver”). Videotaped responses were scored by a clinical
neuropsychologist (JF).
Results: Ninety-three LDs were assessed. Mean (standard deviation;
domain maximum) scores were as follows: Understanding: 18.1 (2.6;
max = 22), Appreciation: 5.1 (1.0; max = 6), Reasoning: 3.1 (0.8;
max = 4), and Final Choice: 3.8 (0.5; max = 4). Scores did not diﬀer by
demographics, relationship to the recipient, eligibility to donate, or
eventual donation (p > 0.4). Higher education was associated with
greater Understanding (p = 0.004) and Reasoning (p = 0.03).
Conclusion: Standardized, computerized education with independent
ratings of responses may (1) alert the clinical staﬀ to potential donors
who may not be competent to donate and (2) highlight areas needing
further assessment and education, leading to better informed decision
making.
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Adult-to-adult living donor liver transplantation
(LDLT) is an alternative to deceased donor trans-
plantation that can reduce waiting time and
improve outcomes (1). This procedure presents dif-
ﬁcult choices to patients and families, as it requires
the living donor (LD) to undergo an operation
with an estimated risk 10-fold that of donating a
kidney (2, 3). The death of an LD immediately
after donation in 2002, and two more donor deaths
in 2010 (4), led to increased scrutiny of the living
donation process. In 2002, the Advisory Commit-
tee on Organ Transplantation (ACOT) developed
18 consensus guidelines to make the process as
“safe and eﬀective as possible, for both the living
organ donor and the recipient,” while maintaining
the eﬃcacy of living donation and transplantation
(http://organdonor.gov/legislation/acotrecs118.html).
Foremost among these guidelines is that suitable
donors be competent. Subsequently, international
conferences organized by The Transplantation
Society on care of live kidney (2003) and extrarenal
(2005) donors reaﬃrmed that live organ donors
must be competent (5–7). Competence to agree to
an LDLT entails several abilities, including com-
prehension, appreciation, reasoning, and decision
making that have been deﬁned in the literature and
have become the basis for objective evaluation in
both medical and legal settings (8, 9). Despite con-
sensus regarding the requirement of competence,
there is no standard metric for measuring compe-
tence, and the process of assessment varies widely
based on local standards (10–12).
The Adult-to-Adult Living Donor Liver Trans-
plantation Cohort Study (A2ALL), a consortium
of nine U.S. transplant centers tasked to study
adult-to-adult LDLT between 2002 and 2009,
included potential donors and recipients in a retro-
spective (1998–2003) and prospective (2004–2009)
study of clinical practice and outcomes. During the
retrospective study (13), we recognized that the
nine centers did not assess competence-related abil-
ities uniformly. Based on the competence domains
noted above, we adapted the MacArthur Compe-
tence Assessment Tool for Clinical Research (Mac-
CAT-CR) for LDs (“MacLiver”) to provide
information about the living donation process in a
standardized computer format and query the sub-
ject’s ability to comprehend and make choices. We
sought to provide an initial competence screening
that could inform the transplant staﬀ of areas of
lower comprehension in potential donors so that
educational eﬀorts or evaluations could be appro-
priately targeted.
The speciﬁc goals of this study were to assess the
inter-rater reliability of MacLiver scoring, develop
preliminary normative distributions for domain-
speciﬁc scores, and assess covariate eﬀects on these
scores. The longer-term goal was to assess this tool
for use in clinical practice.
Participants and methods
A2ALL cohort study and methods
Participant enrollment into the prospective arm of
A2ALL has been described elsewhere (14). In brief,
all prospective LDs were eligible. On the day the
prospective LD was ﬁrst evaluated at the trans-
plant center, the study intervention was explained
and the opportunity to enroll was oﬀered. Follow-
ing enrollment, the MacLiver was the ﬁrst center-
provided educational material given and was given
only at the start of the ﬁrst visit. All study proce-
dures were approved by the institutional review
board (IRB) at each study site and at the data
coordinating center (DCC), and written informed
consent was obtained from all participants. We
note that the requirement of informed consent for
this study guaranteed a level of competence for
study participants.
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The MacArthur Competence Assessment Tool for
Clinical Research
The MacCAT-CR is a structured format to assess
competence of participants in clinical research (15)
that can be adapted for a variety of research set-
tings. It is widely used to assess patients in whom
competence is uncertain, such as those with Alzhei-
mer’s disease or psychiatric disorders (16, 17), and
its psychometric properties are well established
(18). The MacCAT-CR is typically designed for a
live interview setting. However, in adapting the
MacCAT-CR for the LD setting, it was modiﬁed
into a computer-administered presentation to
provide a standardized education and assessment
format at the nine A2ALL clinical centers and was
given the name MacLiver.
The script of the educational component was
created by the members of the A2ALL consortium
to meet ACOT guidelines for information about
the donation process, risks, and outcomes to dis-
close to prospective LDs as part of the informed
consent process. Based on the script, Paul Appel-
baum, MD, coauthor of the MacCAT-CR, assisted
in generating the MacLiver to speciﬁcally (i) pro-
vide standardized education and (ii) uniformly
assess competence in the prospective LD popula-
tion. The MacLiver script and the comprehension
questions (see SDC, Appendix), read by profes-
sional actors, were produced and adapted for video
presentation on a tablet computer by Clinaero,
Inc. (Bellevue, WA, USA; www.clinaero.com).
The tablet computer presentation included indi-
vidual modules, each containing a short educational
lecture immediately followed by a question/answer
session where the potential LDs’ answers were cap-
tured by a built-in microphone and camera. The
modules comprised the MacLiver competence
domains: understanding the donor evaluation pro-
cess, understanding the risks and beneﬁts of dona-
tion, understanding the right to refuse without
consequence, appreciating the impact of donation,
expressing a clear decision to move forward or not,
and providing clear reasoning for that decision.
Responses were uploaded from the tablets to Clin-
aero, Inc., which forwarded the ﬁles to the study
psychologist (JF) for scoring, as described below.
Due to a combination of problems including
clinic logistics (primarily the earlier arrival time
required to take theMacLiver before clinical visits),
Clinaero software problems, and patient refusals,
only 169 of 721 (23%) LDs participated in the elec-
tronic portion of the data collection. Of these, 31
ﬁles had insuﬃcient recorded responses (fewer than
13 of 18 responses) and 45 were not recovered from
the tablets, leaving 93 scorable ﬁles. Of these, 76
contained both audio and video information (AV),
while 17 were “audio-only” ﬁles due to additional
video recording complications. The latter ﬁles were
coded solely using the audiotaped responses.
Scoring of the MacLiver
The assessment component of the MacLiver
encompassed 18 questions categorized into four
domains. Understanding comprised four subdo-
mains: knowledge of the components of the pro-
spective LD evaluation, the purpose of the
MacLiver evaluation, the possible risks and bene-
ﬁts, and understanding the right to terminate the
evaluation process at any time without repercus-
sion (11 questions). Appreciation reﬂected how the
risks and beneﬁts could speciﬁcally impact the life
and well-being of the prospective LD (three ques-
tions). Reasoning related to the rationale used to
make the decision to donate (two questions).
Lastly, Final Choice referred to the ability to
express a clear decision (two questions). Each ques-
tion was scored as 2, 1, or 0 points. A score of 2
was assigned when responses indicated good com-
prehension of all required elements (see SDC,
Appendix) and/or reﬂected good application of the
information, including but not limited to that given
by the script. A score of 1 was assigned when a key
element of information was missing or if an overly
vague or concrete answer was provided. Zero
points were given for responses that were inaccu-
rate, fully insuﬃcient, or when the respondent
could not provide a response.
Clinical donor evaluation process
Following the MacLiver, prospective LDs under-
went center-speciﬁc clinical evaluation. The assess-
ment determined mental and physical suitability,
including motivation, medical evaluation of overall
health, suitability and morphology of the liver, and
psychosocial evaluation of competence to consent
for donation. Under the A2ALL protocol, accep-
tance for donation was determined by the local
evaluating team using local standards to determine
competence and psychosocial stability. The clinical
teams evaluating the donors were blinded to the
MacLiver assessment. Clinical data elements,
including whether the prospective LD was ruled
out for donation and the reason for the rule out,
were recorded in the A2ALL database.
Post-donation perception of donation items
For those who donated, we collected data
three months post-donation via a standardized sur-
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vey on LDs’ perceived preparation for donation,
perceived stress about the donation experience, and
overall feelings about living donation (19). We com-
pared these items betweenMacLiver completers and
non-completers to determine whether completing
the MacLiver predicted their sense of preparedness
or feelings about the donation experience.
Data analysis
Multiple imputation was used to impute the miss-
ing items for participants with complete data for at
least 13 of the 18 MacLiver items (20–22). Five
imputation data sets were generated, and all subse-
quent analyses were performed by pooling the
results from these ﬁve data sets. The SASTM MI
and MIAnalyze procedures were used for the
imputation and subsequent analyses. Comparisons
between groups were performed using two-sample
t-tests for continuous variables, and using chi-
square tests for dichotomous variables.
Results
Study population and demographics
Table 1 compares demographic and other charac-
teristics of potential donors who did and did not
complete the MacLiver. In general, the MacLiver
participants were more likely to have education
beyond high school and were also more likely to
donate, partly because the non-MacLiver group
had more contraindications in their potential recip-
ients. Overall, participants had a mean age of
39 years, were nearly equally divided by sex, were
predominantly non-Hispanic white, and most had
education beyond high school. Nearly two-thirds
of participants were biologically related to the can-
didate. Over half of the evaluated donors did not
donate, largely due to medical and anatomical con-
traindications or changes in the situation of the
recipient.
Inter-rater reliability of MacLiver scoring
For a subset (n = 31) of MacLiver recordings, in
addition to scoring by the study neuropsychologist
(JF), a trained research assistant provided a second
independent rating to assess scoring reliability. Of
the scorable items, 90% matched exactly and four
items (1%) diﬀered by two points (Table 2). Three
of the four were for the same prospective LD, the
ﬁrst one co-rated. The diﬀerences were due to con-
ﬂicting conventions on whether LD response mate-
rial given later in the questioning could be credited
to an earlier question. By consensus, subsequent
scoring allowed all information to be credited to any
question. For the subsequent analyses of co-rated
participants, the average rater scores were used.
When the inter-rater reliability was examined for
the four domains, ratings for Appreciation and
Reasoning appeared to have more discrepancies
Table 1. Prospective living donor characteristics
Characteristics
MacLiver a
(n = 169)
Non-MacLiver
(n = 552)
p-Value
N (%) or
Mean (SD)
N (%) or
Mean (SD)
Age 39 (10.6) 38 (10.6) 0.33
Sex
Male 81 (48%) 282 (51%) 0.47
Female 88 (52%) 270 (49%)
Ethnicity
Hispanic/Latino 22 (13%) 88 (16%) 0.35
Non-Hispanic/
Non-Latino
147 (87%) 464 (84%)
Race
White 155 (92%) 482 (87%) 0.12
Non-white 14 (8%) 70 (13%)
Education
High school or less 40 (24%) 127 (23%) 0.001
Technical school 38 (22%) 124 (22%)
Associate/Bachelor
degree
66 (39%) 144 (26%)
Post-college graduate
degree
11 (7%) 53 (10%)
Unknown/missing 14 (8%) 104 (19%)
Relatedness to recipient
Biologically related
Parent 8 (5%) 18 (3%) 0.19
Child 48 (28%) 189 (34%)
Sibling 37 (22%) 84 (15%)
Other biological 16 (9%) 51 (10%)
Not biologically related
Spouse 7 (4%) 40 (7%)
Other non-biological 46 (28%) 149 (28%)
Unrelated 4 (2%) 3 (1%)
Missing 3 (2%) 18 (3%)
Recipient liver disease
ETOH 7 (4%) 35 (6%)
Not ETOH 162 (96%) 517 (94%) 0.29
Donation status
Donated 66 (39%) 175 (32%) 0.03
Accepted, but did not
donateb
8 (5%) 60 (11%)c
Not accepted to donate 95 (56%) 316 (57%)
Reason for non-acceptance
Medical
contraindications
79 (83%) 272 (86%) 0.75
Non-medical
contraindications
7 (7%) 21 (7%)
Declined to donate 9 (9%) 23 (7%)
aOf 169 donors who attempted the MacLiver, files for 93 could be recov-
ered and scored.
bReasons for non-donation after acceptance related to recipient condition
included the following: candidate condition worsened/removed from
transplant consideration, candidate condition improved/removed from
transplant consideration, or candidate received a DDLT.
cExcluded one donor who had no accept or decline information.
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than for Understanding and Final Choice, which
may indicate greater subjectivity in scoring those
components. Diﬀerences in total score (maximum
total score = 36) ranged from 3 to +2, and raters
were not systematically diﬀerent (paired t-test,
df = 30, p = 0.20). The absence of video did not
aﬀect inter-rater reliability (Table 2), but the
presence of video provided information about rare
but important contextual inﬂuences on partici-
pants’ responses (e.g., one respondent holding an
infant and another being given answers by another
person in the room).
Distribution of scores
Fig. 1a shows boxplots of the score distributions for
the four elements of competence (Understanding,
Appreciation, Reasoning, and Final Choice), and
Fig. 1b shows the subscale scores for each area of
Understanding, both for those scored with audio
information only (A) and those with both (AV). No
signiﬁcant diﬀerences between the A and AV groups
were seen for any of the MacLiver scales (two-sam-
ple t-test, df = 91: Understanding, p = 0.52; Appre-
ciation, p = 0.82; Reasoning, p = 0.09; Final
Choice, p = 0.49). Table 3 gives means and stan-
dard deviations for each domain (combining A and
AV). The total score is not reported as it is not clini-
cally interpretable; competence can be impaired by
poor performance on any one domain even if intact
across other domains (14).
Of particular interest are those participants whose
scores placed them in the lowest quartile on each of
the competence-related abilities (i.e., below the box
in Fig. 1a). Although this study did not attempt to
establish a quantitative cutoﬀ for adequate perfor-
mance of competence-related abilities, 18–20% of
participants had scores one standard deviation or
more below the mean on Understanding, Apprecia-
tion, or Reasoning. The participants falling into
these categories did not diﬀer from other partici-
pants on the basis of any demographic variable.
There were perfect scores across all prospective LDs
in expressing their understanding of the right to
refuse further evaluation and to do so without con-
sequence. Near-perfect ability to express a clear
choice was also evident across the sample.
Association between MacLiver scores and
demographics, relatedness, and donor disposition
Components of the MacLiver were assessed for
diﬀerences among demographic subgroups
(Table 3). No diﬀerences were seen by age, sex,
ethnicity, race, relationship to the recipient,
whether accepted for donation, or completed
donation. In contrast, those with more education
(Associate’s degree and higher vs. technical degree
and lower) had signiﬁcantly higher MacLiver
scores for both Understanding and Reasoning.
Neither met the criterion for signiﬁcance after
Bonferroni adjustment, but it is unusual that both
results were for the same variable.
Relation of MacLiver to local competence assessment
None of the prospective LDs evaluated by the
MacLiver were subsequently deemed unable to
provide informed consent to living donation by the
local standard of psychiatric, psychological, and/
or social worker assessments.
Impact of MacLiver on perceptions of donation
Both the MacLiver and three-month post-donation
survey were completed by 36 donors. These donors
were as likely as donors who had not completed
the MacLiver (n = 87) to report that the informa-
tion they had received was clear (94% vs. 95%),
they were well prepared for donation (82% vs.
83%), and they had positive attitudes about living
donation in retrospect (79% vs. 78%). However,
the subset of donors completing the MacLiver was
signiﬁcantly less likely to report that the donation
Table 2. Inter-rater reliability for audio-only and audio plus video, overall, and by MacLiver domain (Understanding, Appreciation, Reasoning,
and Final Choice). Table entries are the n (%) of scorable itemsa
Domain
Audio only (n = 8) Audio + Video (n = 23)
Exact match
1 category
different
2 categories
different Kappa Exact match
1 category
different
2 categories
different Kappa
Understanding 76 (89%) 8 (9%) 1 (1%) 0.80 226 (95%) 13 (5%) 0 0.89
Appreciation 21 (91%) 2 (9%) 0 0.70 53 (83%) 10 (16%) 1 (1%) 0.63
Reasoning 14 (88%) 2 (12%) 0 0.76 32 (76%) 9 (21%) 1 (3%) 0.54
Final Choice 15 (94%) 1 (6%) 0 0.64 39 (93%) 2 (5%) 1 (2%) 0.70
All Domains 126 (90%) 13 (9%) 1 (1%) 0.79 350 (90%) 34 (9%) 3 (1%) 0.80
aThere was no significant difference in the proportion of exact matches between audio only and audio+video for any domain or overall.
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experience was “very” or “pretty stressful” (39%
vs. 68%, p = 0.006).
Discussion
The prospective enrollment of living liver donors
(LDs) in the A2ALL consortium provided an
opportunity to develop and evaluate a standard-
ized educational tool and quantitative assessment
for competence-related abilities (MacLiver) in the
setting of living liver donation. This was accom-
plished using a self-administered program designed
for tablet computers, created speciﬁcally for the
study. We aimed to develop a tool to augment cen-
ter-speciﬁc donor evaluations by identifying areas
of reduced donor comprehension and possible
issues with donor competence to consent to liver
donation.
The cohort of participants in the MacLiver pro-
cess, although only 23% of the total prospective
donor population, were similar to those who did not
participate due to refusals and technical problems.
There were no statistically or clinically meaningful
A
B
Fig. 1. (a). Boxplot distributions of
scores, with a circle for each
observation overlaid for each
component of competence (each circle
may represent more than one data
point), separately for those scored
using audio information only
(A, n = 17) and audio plus video
information (AV, n = 76). Each item
was scored as 0, 1, or 2, and the
subscale scores are the sum of item
scores. Understanding (11 items),
Appreciation (three items), Reasoning
(two items), and Final Choice (two
items). Boxes include the 25th to 75th
percentiles; the middle line indicates the
median. Whiskers extend from each
end of the box to the farthest data
point within 1.5 times the interquartile
range (IQR). (b) Boxplot distributions
of scores with a circle for each
observation overlaid (each circle may
represent more than one data point) for
each component of Understanding,
separately for those scored using audio
information only (A, n = 17) and audio
plus video information (AV, n = 76).
Each item was scored as 0, 1, or 2, and
the subscale scores are the sum of item
scores. U1: Understanding the purpose
and components of the evaluation
process (four items), U2:
Understanding the purpose and
method of this MacLiver research
(three items), U3: Understanding the
risks and beneﬁts of undergoing the
donor evaluation process (two items),
and U4: Understanding the right to
stop the evaluation at any time without
consequence (two items). Boxes include
the 25th to 75th percentiles; the middle
line indicates the median. Whiskers
extend from each end of the box to the
farthest data point within 1.5 times the
interquartile range (IQR).
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diﬀerences in MacLiver performance based on
donor demographics or disposition, beyond educa-
tion. Also, we found no MacLiver diﬀerences when
comparing biological vs. non-biological potential
donors, spouses vs. other categories, or alcohol as a
cause of recipient liver failure vs. other categories.
We were pleased to ﬁnd that all prospective
donors could express their understanding that they
had the right to refuse donation and further evalu-
ation at any time and do so without consequence.
Nearly all could express a clear ﬁnal choice about
their decision. As expected, there was greater vari-
ability in Appreciation and Reasoning than in
other domains, relative to the respective numbers
of questions, which may be due to subjectivity in
the scoring of these qualitative responses.
Education was associated with certain compe-
tence-related domains. Those with a higher level of
education obtained higher MacLiver Understand-
ing and Reasoning scores than those with less
education, as has been observed with the MacCAT-
CR in other settings (23). In addition to the impact
of baseline education on scores, remedial education
to enhance Understanding and Appreciation posi-
tively aﬀected MacCAT-CR performance in
depressed (24) and schizophrenic (25) participants
assessed for competence to undergo treatment or
consent to research.
Completing the MacLiver did not appear to
aﬀect prospective LDs’ satisfaction post-donation.
Those who took the MacLiver did report less stress
about the donation, but this could reﬂect either a
causal eﬀect or a selection of more resilient donors
who consented to undergo the MacLiver. Whether
personality traits diﬀer between those willing to
consent to an added research component and those
who do not could be examined in a future study
using a tool such as the NEO PI-3 (26). In general,
however, it is not so surprising that the MacLiver,
which was a small part of the entire donor evalua-
tion process, had little lasting eﬀect on donor
preparedness or attitudes about donation.
The MacLiver provided insight into how pro-
spective LDs with no prior education from the
donor evaluation team demonstrate their compe-
tence-related abilities to understand, appreciate,
Table 3. Performance on the MacLiver by characteristics of the donors (N = 93)
Characteristic
Understanding (max = 22) Appreciation (max = 6) Reasoning (max = 4) Final Choice (max = 4)
Mean  SD Mean  SD Mean  SD Mean  SD
Overall
Age 18.1  2.6 5.1  1.0 3.1  0.8 3.8  0.5
≤38 yr 17.9  2.8 4.9  1.0 3.1  0.7 3.9  0.5
>38 yr 18.4  2.4 5.2  1.0 3.1  0.9 3.8  0.5
Sex
Female 18.1  2.6 5.0  1.0 3.2  0.7 3.9  0.5
Male 18.1  2.7 5.1  1.1 3.0  0.8 3.8  0.5
Ethnicity
Hispanic 17.5  3.1 5.0  1.1 3.2  0.8 3.8  0.7
Non-Hispanic 18.2  2.6 5.1  1.0 3.1  0.8 3.8  0.5
Race
Non-white 17.0  3.0 5.1  0.5 3.0  0.0 3.9  0.2
White 18.2  2.6 5.1  1.1 3.1  0.8 3.8  0.5
Educationa
>High school 19.0  2.1b 5.2  0.9 3.3  0.8b 3.8  0.5
≤High school 17.5  2.7 4.9  1.2 2.9  0.7 3.8  0.5
Relatedness to recipienta
Biological 18.1  2.7 5.1  1.0 3.1  0.8 3.8  0.5
Non-biological 18.1  2.6 5.0  1.1 3.1  0.7 3.8  0.4
Accepted for donation
Accepted 18.2  2.6 5.1  1.0 3.1  0.8 3.8  0.5
Not accepted 18.0  2.7 5.0  1.1 3.2  0.8 3.9  0.4
Donated status
Donated 18.2  2.6 5.0  1.0 3.1  0.8 3.8  0.6
Not donated 18.1  2.6 5.1  1.0 3.1  0.8 3.9  0.4
Cause of liver failure in intended recipient
Alcohol 18.6  1.5 5.4  0.8 3.3  0.7 3.9  0.3
Not alcohol 18.1  2.7 5.0  1.0 3.1  0.8 3.8  0.5
SD, standard deviation. Bold values indicate education level beyond high school was associated with significantly higher Understanding and Reasoning
scores.
aEducation missing/unknown for n = 17; relatedness to recipient missing/unknown for n = 20.
bEducation effect for Understanding, p = 0.006; Appreciation, p = 0.1556; Reasoning, p = 0.0241; Final Choice, p = 0.8432.
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reason, and express a clear choice in response to
standardized preliminary education. It is premature
to qualify these data as “normative,” but this sam-
ple was demographically consistent with the large
range of prospective live LDs seen in our multicen-
ter retrospective experience and in other reports
(13, 14, 16, 17). Given that these abilities, as compo-
nents of competence, are necessary for regulatory
compliance, these data may oﬀer useful guidance
on improving the process of donor assessment.
Individual performances on the MacLiver
revealed considerable variability. Although no
individual scored more than 1 standard deviation
below all domain means, several clear outliers
appeared within speciﬁc domains. Such individuals
may be a group whose performance warrants more
in-depth evaluation; a tailored, individualized
approach to education; or further assessment. The
latter is currently under development (EJ Gordon,
1R03DK091786-01).
Among the MacLiver participants, we expected
a low exclusion rate due to competence-related
deﬁciencies because they were required to provide
written informed consent before performing the
MacLiver module. Across the nine participating
transplant centers, the local standard of medical,
psychosocial, and psychiatric evaluations yielded
only two prospective LDs who were ruled out
for “psychosocial contraindications.” These two
scored near or above the sample mean on the Mac-
Liver domains, illustrating that performance on
competence-related measures is only one of several
issues that may lead otherwise medically suitable
participants to be declined as donors. Although
the MacLiver provides useful clinical information,
it does not replace clinical judgment. It does, how-
ever, reduce the potential for evaluator bias in
determining donor eligibility, providing more rig-
orous protection to this donor population.
Our experience with the MacLiver can provide
guidance for future implementations. Early admin-
istration of the MacLiver can yield a “needs assess-
ment” of areas important to competence, which is
consistent with the intent of the MacCAT-CR (15)
and its use in other studies (16, 23–25). Use of the
tablet to standardize the educational component at
a prospective donor’s initial visit can be time-
saving for center personnel and ensure that all
prospective donors receive uniform instruction.
Timely provision of MacLiver scores to center staﬀ
can highlight the need for additional education to
aid the potential LD in decision making. Retention
of knowledge could be tested at a second visit to
assess how well a prospective donor sustains com-
petency over time. Increased educational consis-
tency, protecting prospective LDs by identifying
atypical performance, and timely assessment with
minimal investment of center resources are the
main strengths of this method.
A bitter lesson from our study was the impor-
tance of thoroughly testing computer technology
before use in the clinic. Although we had reviewed
and approved the MacLiver educational segments,
which were well done and well received, we did not
suﬃciently test the data acquisition and upload
features. Centers had a variety of technical issues,
some of which were diﬃcult to solve. Delays
occurred due to communication lags between the
data coordinating center, the clinical centers, and
Clinaero. In spite of these problems, we would still
recommend a video interface for the educational
components, which was successful in our imple-
mentation. For the query components, the video
recording of subjects’ answers, which require scor-
ing by a psychologist, may not be feasible in terms
of time or cost in a transplant clinic. One cost-
eﬀective alternative would be a short answer or
multiple-choice test, preferably by computer, so
that scores could be immediately sent to relevant
transplant staﬀ for planning the next step of the
donor evaluation process.
There are important limitations to the study.
First, the MacCAT-CR format on which the
MacLiver is based was developed for live interac-
tion with an experienced interviewer, wherein par-
ticipants have repeated opportunity to
demonstrate the extent of their decisional abilities
(27). Although probing an individual’s response
could reveal either more or less comprehension,
uncovering knowledge deﬁcits and re-disclosing
information are likely to result in higher scores
via the “teach-back” method (28). With non-
interactive computerized administration, this
advantage was lost. Second, the technology used
was not accessible to all patients due to a lack of
familiarity with computers, limitations in commu-
nication ability, or language barriers (29). Third,
the approach complicated the clinical ﬂow. Study
coordinators reported that the earlier arrival time
required to take the MacLiver before clinical vis-
its was a primary deterrent for the 77% who did
not participate. Lastly, the technology had fail-
ures in recording and downloading responses,
and some users could not navigate the system
eﬀectively. These issues combined to create a sub-
stantial loss of potential participants for the Mac-
Liver evaluation. Although we ascertained that
the subset that attempted the MacLiver did not
diﬀer from the overall cohort on any measured
dimension, the possibility of unmeasured diﬀer-
ences cannot be excluded. In future implementa-
tions, computer literacy and language capacity
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could be accommodated, for example, by provi-
sion of a brief computer training program or pro-
viding translated versions for common non-
English languages (30). An advantage of the
MacLiver is that it provided a uniform instruc-
tional approach to potential donors at all nine
A2ALL clinical centers. If updated to include
current federally mandated, consensus driven
information, it may be useful as a preliminary
education tool that could be viewed at the start
of an initial prospective LD clinic visit.
In conclusion, we have evaluated a novel
approach for standardized education and assess-
ment of competence in prospective LDs. Potential
donors who were judged competent by conven-
tional local assessments generated a range of pre-
sumably acceptable MacLiver scores, but also
included outliers who may need tailored evaluation
and education. Despite methodological diﬃculties,
this is an important ﬁrst step in implementing stan-
dardized education and preparation for compe-
tence assessment among potential LDs.
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SDC, Appendix
MacArthur Competence Scale, script adapted
for the Adult-to-Adult Living Donor Liver
Transplantation Cohort Study (A2ALL): MacLiver
Understanding -1 (U-1)
Disclosure: Purpose of the evaluation process and
what its components are:
“People who are thinking of donating part of
their liver to another person ﬁrst must go
through an evaluation process. The goals of the
evaluation are to be sure that (i) the donor is
healthy and can undergo major surgery and (ii)
the donor’s liver is the right match for the recipi-
ent. Potential donors will undergo a thorough
history and physical examination, interviews
with health care professionals, and a variety of
x-ray and blood tests. Also, because donating
part of a liver can impact donors’ lives in ways
beyond their physical health, social workers and
others will talk with donors and their families
about the emotional and social consequences.”
U-1a “What has to occur before someone can
donate part of their liver to another person?
Answer: An evaluation process (if further
details mentioned at this point, credit could
also be applied to subsequent answers to
U-1b, 1c, and 1d below as appropriate).
641
MacLiver and organ donation
U-1b “What are the goals of the evaluation pro-
cess?”
Answer: See if potential donors are (i) healthy
enough to have surgery and (ii) if their livers
are good matches for the recipients.
Two points for both concepts: 1 point for one
concept and 0 points if neither concept
expressed.
U-1c “What will the evaluation process
involve?”
Answer: History and physical, blood and lab
tests, x-rays. Other tests may also be
mentioned (e.g., ultrasound). Two points for
both H and P, and one or more other tests;
1 point for either H and P or 1 test; 0
points if neither H and P or any other tests
mentioned.
U-1d “What other things will occur?”
Answer: Interviews for personal and social
assessments (or speciﬁcally identifying
meetings with a social worker, psychologist,
and/or psychiatrist).
Two points for identifying those portions of the
evaluation are non-medical in nature as
above: 1 point for adding another
appropriate medical test at this point and 0
points if neither.
Understanding-2 (U-2)
Disclosure: Purpose of this study: Research on
decision making about the donation:
“In addition to performing liver transplants, this
center is part of a research group that is trying
to learn about why people decide to donate
parts of their livers, and how donation aﬀects
their long-term quality of life. This involves ask-
ing all potential donors a series of questions
during the evaluation process and again after
the transplant takes place—even if they don’t
end up donating part of their liver.”
U-2a “What is this transplant center trying to
learn about potential LDs?”
Answer: Determine (i) their motives and
(ii) long-term outcomes.
Two points for both concepts: 1 point for one
concept and 0 points if neither concept.
U-2b “How will this information be gathered?”
Answer: All potential donors will be assessed
through the administration of standardized
tests.
U-2c “Will everyone be asked to answer these
questions, even if they don’t donate part of their
liver?”
Answer: Yes.
Understanding- 3a (U-3a)
Disclosure of possible Beneﬁts:
“There are several potential personal beneﬁts
from being considered as a LD. By undergoing
a thorough medical evaluation, it is possible that
previously unknown disorders might be identi-
ﬁed and treated. In addition, if the donor is
found to be healthy and goes through with the
liver donation, the donor may derive a deep per-
sonal satisfaction from giving the chance for
continued life to another person.”
U-3a “What possible beneﬁt could come from
being evaluated for liver donation”?
Answers: 1. Personal satisfaction.
2. Possible discovery of an otherwise unknown
disorder.
Two points for both concepts: 1 point for one
and 0 points if neither.
Understanding-3b (U-3b)
Disclosure of Risks:
“Although every eﬀort is made to assure that
the risk of liver donation is minimal, a variety of
risks are taken by the LD. In the US, there have
been two deaths in the roughly 1000 liver dona-
tions that have been done to date. Moreover,
donors experience the pain and discomfort that
comes with a major abdominal operation.”
U-3b “What sorts of risks might a donor experi-
ence?”
Answers: 1. Death
2. Pain and discomfort from major surgery.
Others may be mentioned, but the speciﬁc possi-
bilities of death and certainty of pain must be iden-
tiﬁed.
Two points for both concepts: 1 point for one
and 0 points if neither.
Understanding-4a (U-4a)
Disclosure of the Right to refuse to be a donor
without consequence:
“No one has to donate a portion of his or her
liver, even if they have begun the evaluation
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process. Potential donors can decline to proceed
with any further testing or with the operation at
any time. No one will be told the reason why a
potential donor decided not to proceed and
there will be no charge for the evaluation that
was done.”
U-4a and 4b: “Once entering the evaluation pro-
cess, does a potential donor have to donate part of
their liver? What will happen to them if they decide
not to donate?”
Answer: 1. Absolute free choice for donation.
2. No adverse consequence of not donating.
Two points for both concepts: 1 point for one
and 0 points if neither.
Appreciation (A 1-3):
A-1 “Do you believe that the primary reason for
donating your liver is for your own beneﬁt?”
Answer: No personal physical beneﬁt.
A-2 “Do you think that something injurious or
painful could happen if you donated your liver?”
Answer: Reasonable risk that something
might happen- low risk of death, 100%
risk of pain
Two points if answer included 1 or more
speciﬁc outcomes: 1 point for simple
answer “yes” and 0 points if LD did not
express risk.
A-3 “What do you believe would happen if you
were to decide not to donate your liver?”
Answer: Nothing to the donor, may speak
about family or recipient.
Expressing a Final Choice (E)
E-1 “You have expressed an interest in being a
LD. Do you think that you are likely to want to
proceed on towards liver donation or not likely to
donate?”
Record answer (must be a clear statement to
receive full credit).
Reasoning (R)
R-1 [Consequential/Comparative Reasoning] “Tell
me why you thought that option was the right
choice for you.”
Record answer (must include a clear statement
about what facts, potential risks/beneﬁts, and
beliefs were considered in expressing a clear
rationale to receive full credit).
R-2 [Generating Consequences] “I have told you
about some of the possible beneﬁts and risks and dis-
comforts of donating a portion of your liver. The
major beneﬁt is the personal satisfaction that you
have helped someone that would die without a liver
transplant. The risks include the pain and discomfort
that you will experience and the very small chance
that you could die. How do you think liver donation
would aﬀect your everyday life, including your job,
your life at home, and your family relationships”?
Answer: At least two eﬀects on everyday life.
Two points for two or more eﬀect: 1 point for
one eﬀect and 0 points if expressed belief that
nothing would change.
Expression of final choice
E-2 “A few minutes ago you expressed a choice
about whether to proceed on with the process of
liver donation. What do you think now that we
have discussed everything? What do you want to
do now?”
Record answer (must be a clear statement to
receive full credit).
Appendix (The A2ALL Study Group)
The A2ALL Study Group includes Northwestern
University, Chicago, IL; University of California—
Los Angeles, CA; University of California—San
Francisco, CA; University of Colorado Health Sci-
ences Center, Denver, CO; University of North
Carolina, Chapel Hill, NC; Epidemiology and Clin-
ical Trials Branch, Division of Digestive Diseases
and Nutrition, National Institute of Diabetes and
Digestive and Kidney Diseases, National Institutes
of Health, Bethesda, MD; University of Michigan,
Ann Arbor, MI; Department of Surgery, Columbia
Presbyterian Medical Center, New York, NY; Uni-
versity of Pennsylvania, Philadelphia, PA; Depart-
ment of Internal Medicine, University of Virginia,
Charlottesville, VA; and Virginia Commonwealth
University, Richmond, VA. The following individ-
uals were instrumental in the planning, conduct,
and/or care of patients enrolled in this study at each
of the participating institutions, Columbia Univer-
sity Health Sciences, New York, NY (DK62483):
principal investigator, Jean C. Emond, MD; co-
principal investigator, Robert S. Brown, Jr., MD,
MPH; study coordinators, Scott Heese, BA, and
Taruna Chawla, MD; Northwestern University,
Chicago, IL (DK62467): principal investigator,
Michael M.I. Abecassis, MD, MBA; co-principal
investigator, LauraM. Kulik, MD; study coordina-
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tor, Patrice Al-Saden, RN, CCRC; University of
Pennsylvania Health System, Philadelphia, PA
(DK62494): principal investigator, Abraham Sha-
ked, MD, PhD; co-principal investigator, Kim M.
Olthoﬀ, MD; study coordinators, Brian Conboy,
PA, MBA, and Mary Shaw, RN, BBA; University
of Colorado Health Sciences Center, Denver, CO
(DK62536): principal investigator, Gregory T.
Everson, MD; co-principal investigator, Igal Kam,
MD; study coordinator, Andrea Herman, RN;
University of California Los Angeles, Los Angeles,
CA (DK62496): principal investigator, Johnny C.
Hong, MD; co-principal investigator, Ronald W.
Busuttil, MD, PhD; study coordinator, Janet
Mooney, RN, BSN. The principal investigator for
LADR was Sammy Saab, MD, University of Cali-
fornia San Francisco, San Francisco, CA
(DK62444): principal investigator, Chris E. Freise,
MD, FACS; co-principal investigator, Norah A.
Terrault, MD; study coordinator, Dulce MacLeod,
RN; University of Michigan Medical Center, Ann
Arbor, MI (DK62498): principal investigator, Rob-
ert M. Merion, MD; data coordinating center staﬀ,
Anna S.F. Lok, MD, Akinlolu O. Ojo, MD, PhD,
Brenda W. Gillespie, PhD, Margaret Hill-Calla-
han, BS, LSW, Terese Howell, BS, CCRC, Lisa
Holloway, BS, CCRC, Monique Lowe, MS, Abby
Smith, BA, and Abby Brithinee, BA; University of
North Carolina, Chapel Hill, NC (DK62505): prin-
cipal investigator, Paul H. Hayashi, MD, MPH;
study coordinator, Tracy Russell, MA; University
of Virginia (DK62484): principal investigator, Carl
L. Berg, MD; study coordinator, Jaye Davis, RN,
and Colleen Green, PA. The principal investigator
for LADR was Abdullah M.S. Al-Osaimi, MD;
Medical College of Virginia Hospitals, Virginia
Commonwealth University, Richmond, VA
(DK62531): principal investigator, Robert A.
Fisher, MD, FACS; co-principal investigator, R.
Todd Stravitz, MD; study coordinators, April Ash-
worth, RN, Andrea Lassiter, BS, and Charlotte
Hoﬀman, RN. The principal investigator for
LADR was Mitchell Shiﬀman, MD; Division of
Digestive Diseases and Nutrition, National Institute
of Diabetes and Digestive and Kidney Diseases,
Bethesda, MD: James E. Everhart, MD, MPH,
Averell Sherker, MD, and Jay H. Hoofnagle, MD.
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